Stellar Biotechnologies, Inc. (SBOTF) Significantly Trims Q2, Six-Month Losses on Higher Revenues
Stellar Biotechnologies, a leading manufacturer of Keyhole Limpet Hemocyanin ("KLH"), an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, Monday posted year-over-year financial improvements for its second fiscal quarter and six months ended March 31, 21015. "Stellar is pleased to issue this mid-year report which shows increased demand for our products, continued financial prudence, and the positive effect of continued focus on our core KLH business," Stellar president and CEO Frank Oakes stated in the news release. "As KLH-based technologies advance through clinical development, we are excited to be in this strong position as the opportunities in the KLH market…